Investigating how SGK1 affects insulin-producing cells in diabetes
SGK1 is a regulator of islet beta cell mass and secretory function
This study is looking at how a protein called SGK1 affects the growth and function of insulin-producing cells in the pancreas, which could help us understand diabetes better and find new ways to manage it, especially by looking at how diet and insulin needs change.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Pennington Biomedical Research Ctr NIH-funded |
| Lab location | 1 site (Baton Rouge, United States) |
| Project ID | NIH-10820411 on NIH RePORTER |
What this research studies
This research explores the role of SGK1, a protein that may regulate the growth and function of insulin-producing beta-cells in the pancreas. By examining how changes in diet and insulin demand influence gene expression in these cells, the study aims to understand the mechanisms behind beta-cell expansion and loss in diabetes. Researchers are using both rodent models and human cells to assess how inhibiting SGK1 affects beta-cell proliferation and insulin secretion, potentially leading to improved glucose tolerance. The findings could provide insights into new therapeutic strategies for diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with obesity or insulin resistance who are at risk of developing diabetes.
Not a fit: Patients with type 1 diabetes or those who do not have issues related to insulin secretion may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance insulin secretion and improve blood sugar control in diabetes patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of beta-cell regulation in diabetes, suggesting that this approach could yield significant insights.
Where this research is happening
Baton Rouge, United States
- Lsu Pennington Biomedical Research Ctr — Baton Rouge, United States (Active)
Researchers
- Principal investigator: Collier, James Jason — Lsu Pennington Biomedical Research Ctr
- Study coordinator: Collier, James Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.